Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM EBIT Multiple | 21.6x - 23.9x | 22.8x |
Selected Fwd EBIT Multiple | 5.6x - 6.2x | 5.9x |
Fair Value | €0.40 - €0.48 | €0.44 |
Upside | -5.0% - 14.7% | 4.8% |
Benchmarks | Ticker | Full Ticker |
EssilorLuxottica Société anonyme | 0OMK | LSE:0OMK |
Surgical Innovations Group plc | SUN | AIM:SUN |
Creo Medical Group PLC | CREO | AIM:CREO |
Cambridge Nutritional Sciences plc | CNSL | AIM:CNSL |
Abingdon Health Plc | ABDX | AIM:ABDX |
INSPECS Group plc | 4GV | DB:4GV |
- | - | - |
Select LTM EBIT Multiple | |||||||
Benchmark Companies | |||||||
0OMK | SUN | CREO | CNSL | ABDX | 4GV | ||
LSE:0OMK | AIM:SUN | AIM:CREO | AIM:CNSL | AIM:ABDX | DB:4GV | ||
Historical EBIT Growth | |||||||
5Y CAGR | 11.3% | NM- | NM- | NM- | NM- | -10.5% | |
3Y CAGR | 15.7% | NM- | NM- | NM- | NM- | -15.1% | |
Latest Twelve Months | 10.3% | -8.5% | -4.9% | 87.0% | 6.7% | 18.2% | |
Historical EBIT Profit Margin | |||||||
5 Year Average Margin | 10.7% | -12.3% | -23396.8% | -12.4% | -122.8% | 1.1% | |
Prior Fiscal Year | 12.4% | -4.9% | -660.0% | -36.0% | -89.3% | 1.4% | |
Latest Fiscal Year | 13.1% | -5.3% | -692.5% | -5.5% | -26.2% | 1.7% | |
Latest Twelve Months | 13.1% | -5.3% | -692.5% | -3.3% | -34.8% | 1.7% | |
Current Trading Multiples | |||||||
EV / LTM Revenue | 4.65x | 0.62x | 11.61x | 0.45x | 3.06x | 0.42x | |
EV / LTM EBITDA | 22.2x | -19.7x | -1.7x | -50.4x | -10.2x | 7.2x | |
EV / LTM EBIT | 35.4x | -11.5x | -1.7x | -13.7x | -8.8x | 24.2x | |
Low | Mid | High | |||||
Benchmark EV / LTM EBIT | -13.7x | -8.8x | 35.4x | ||||
Historical EV / LTM EBIT | -447.9x | 24.2x | 123.0x | ||||
Selected EV / LTM EBIT | 21.6x | 22.8x | 23.9x | ||||
(x) LTM EBIT | 3 | 3 | 3 | ||||
(=) Implied Enterprise Value | 74 | 78 | 82 | ||||
(-) Non-shareholder Claims * | (38) | (38) | (38) | ||||
(=) Equity Value | 35 | 39 | 43 | ||||
(/) Shares Outstanding | 115.3 | 115.3 | 115.3 | ||||
Implied Value Range | 0.31 | 0.34 | 0.37 | ||||
FX Rate: GBP/EUR | 0.9 | 0.9 | 0.9 | Market Price | |||
Implied Value Range (Trading Cur) | 0.35 | 0.39 | 0.43 | 0.42 | |||
Upside / (Downside) | -15.3% | -6.0% | 3.3% |
Equity Waterfall | |||||||
Benchmark Companies | |||||||
(in millions) | 0OMK | SUN | CREO | CNSL | ABDX | 4GV | |
Enterprise Value | 122,505 | 8 | 7 | 4 | 22 | 80 | |
(+) Cash & Short Term Investments | 2,251 | 0 | 9 | 5 | 4 | 24 | |
(+) Investments & Other | 823 | 0 | 43 | 0 | 0 | 0 | |
(-) Debt | (13,216) | (1) | (4) | (0) | (1) | (62) | |
(-) Other Liabilities | (626) | 0 | 0 | 0 | 0 | 0 | |
(-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
(-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
Value of Common Equity | 111,737 | 7 | 54 | 9 | 24 | 42 | |
(/) Shares Outstanding | 461.2 | 932.8 | 402.5 | 238.0 | 375.9 | 115.3 | |
Implied Stock Price | 242.30 | 0.01 | 0.14 | 0.04 | 0.07 | 0.36 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.87 | |
Implied Stock Price (Trading Cur) | 242.30 | 0.01 | 0.14 | 0.04 | 0.07 | 0.42 | |
Trading Currency | EUR | GBP | GBP | GBP | GBP | EUR | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.87 |